Literature DB >> 16399234

Cyclooxygenase-2 plays a suppressive role for induction of apoptosis in isoliquiritigenin-treated mouse colon cancer cells.

Tetsuyuki Takahashi1, Masaki Baba, Hoyoku Nishino, Toru Okuyama.   

Abstract

Cellular damage induced by chronic inflammation is a well known cause of colon carcinogenesis. Cyclooxygenase-2 (COX-2), the enzyme that converts arachidonic acid to prostanoids, is known to play an important role in inflammation. Herbal flavonoid isoliquiritigenin (ILTG) has previously been reported to be a strong suppresser of the COX-2 pathway as well as an inducer of apoptosis. Here we report that the susceptibility to apoptosis by ILTG is dependent on the level of COX-2 in mouse colon adenocarcinoma Colon 26, which spontaneously expresses COX-2. This dependency was observed to be enhanced by blockage of the lipoxigenases (LOXs)-mediated metabolic pathway and attenuated by addition of a number of prostaglandins and thromboxanes. Taken together, these findings indicate that ILTG-induced apoptosis is negatively regulated by the COX-2 expression level.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16399234     DOI: 10.1016/j.canlet.2005.02.025

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Protective Effects of Isoliquiritigenin on LPS-Induced Acute Lung Injury by Activating PPAR-γ.

Authors:  Wenbin Zhang; Gui Wang; Shujun Zhou
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

2.  Dynamic residual complexity of the isoliquiritigenin-liquiritigenin interconversion during bioassay.

Authors:  Charlotte Simmler; Atieh Hajirahimkhan; David C Lankin; Judy L Bolton; Tristesse Jones; Djaja D Soejarto; Shao-Nong Chen; Guido F Pauli
Journal:  J Agric Food Chem       Date:  2013-02-22       Impact factor: 5.279

3.  Ingenol-3-Angelate Suppresses Growth of Melanoma Cells and Skin Tumor Development by Downregulation of NF-κB-Cox2 Signaling.

Authors:  Dunwei Wang; Pengcheng Liu
Journal:  Med Sci Monit       Date:  2018-01-25

4.  A tale of switched functions: from cyclooxygenase inhibition to M-channel modulation in new diphenylamine derivatives.

Authors:  Asher Peretz; Nurit Degani-Katzav; Maya Talmon; Eyal Danieli; Anna Gopin; Eti Malka; Rachel Nachman; Amiram Raz; Doron Shabat; Bernard Attali
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

5.  Targeting oral cancer stemness and chemoresistance by isoliquiritigenin-mediated GRP78 regulation.

Authors:  Fang-Wei Hu; Cheng-Chia Yu; Pei-Ling Hsieh; Yi-Wen Liao; Ming-Yi Lu; Pei-Ming Chu
Journal:  Oncotarget       Date:  2017-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.